|
|
||||||||
Department of Physiology, Michigan State University, East Lansing, Michigan 48824
Submitted 13 October 2003 ; accepted in final form 5 February 2004
Ascorbate reduces the oxidation rate of catecholamines and, by an independent mechanism, enhances rabbit aortic ring contractions initiated by catecholamines. The largest significantly different fractional increases in force produced by ascorbate enhancement of norepinephrine (NE), epinephrine, phenylpropanolamine (PPA), and ephedrine (Eph) are 5.5, 1.8, 1.6, and 1.3 times, respectively. In physiological salt solutions bubbled with 95% O2 at 37°C, NE, PPA, and Eph have oxidation rate constants of 1.24, 247, and 643 h, respectively. Ascorbate significantly enhances 100 nM NE contractions by at least twofold at all ascorbate concentrations >15 µM, including the entire physiological range of 40100 µM. Ascorbate preloading and washout followed by NE exposure produces significantly greater contractions than NE without ascorbate preloading but significantly lower than NE simultaneously with ascorbate. Ascorbate does not enhance K+- or angiotensin II-induced contractions. Ascorbate enhancement of catecholamine contractions occurs in addition to the reduction in oxidation rate, because the increases in force occur faster than oxidation can occur, the increases occur with compounds that have negligible oxidation rates, and the increases occur when ascorbate and NE are not physically present together. These results are consistent with ascorbate acting on the adrenergic receptor. Ascorbate may play a role in shock and asthma treatments and potentiate the cardiovascular health consequences of PPA and Eph (Ephedra).
vitamin C; molecular complementarity; blood pressure
This article has been cited by other articles:
![]() |
P. F. Dillon, R. S. Root-Bernstein, and C. M. Lieder Ascorbate enhancement of H1 histamine receptor sensitivity coincides with ascorbate oxidation inhibition by histamine receptors Am J Physiol Cell Physiol, November 1, 2006; 291(5): C977 - C984. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Flavahan Phenylpropanolamine Constricts Mouse and Human Blood Vessels by Preferentially Activating {alpha}2-Adrenoceptors J. Pharmacol. Exp. Ther., April 1, 2005; 313(1): 432 - 439. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |